Angiex (Seed+)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$18,000,221

Company Info
Founders
Marty Duvall
Company Description
A developer of vascular-targeted biotherapeutics designed to treat cancer. Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics.
Market
Healthcare & Wellness
Coinvestors
Nudel Holdings,Presight Capital

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement